Evidence map›Paper›PMID 40198475›Full record

ReviewJournal of epidemiology and global health2025

Botulism in the Highlands: Understanding the High-Altitude Effect.

Momen Almomen, Ziad Memish

Abstract readReview
In one paragraph

Review in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Momen AlmomenDepartment of Pediatric Neurology, Neuroscience Center, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia. Momenma@moh.gov.sa.
Ziad MemishKing Salman Humanitarian Aid & Relief Center, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulism is a foodborne, life-threatening neuroparalytic disease caused by Clostridium botulinum, an anaerobic, gram-positive, spore-forming bacteria. Its incidence is unknown and underestimated due to missed diagnoses, especially in remote areas. It is divided into four main clinical types: Infant, adult-onset foodborne, iatrogenic, and wound botulism. The overall goal of the article is to focus on the geographic differences in incidence, including its propensity to high-altitude areas, and shed light on the theories behind this propensity.

Indexed as

AltitudeBotulismClostridium botulinumHumansIncidenceBotulismHigh AltitudeNeurotoxicParalysis

Identifiers

PMID40198475
PMCPMC11978557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.